STAT3 and central nervous system cancer: The combined analysis of 12 trials showed that STAT3/p-STAT3 overexpression in glioma was associated with worse OS (HR = 1.40, 95% confidence interval (CI) = 1.05 ~ 1.86, P = 0.020) (Figure 2).